IL153972A0 - Medicaments containing cilansetron for treating non-obstipated male ibs patients - Google Patents

Medicaments containing cilansetron for treating non-obstipated male ibs patients

Info

Publication number
IL153972A0
IL153972A0 IL15397201A IL15397201A IL153972A0 IL 153972 A0 IL153972 A0 IL 153972A0 IL 15397201 A IL15397201 A IL 15397201A IL 15397201 A IL15397201 A IL 15397201A IL 153972 A0 IL153972 A0 IL 153972A0
Authority
IL
Israel
Prior art keywords
obstipated
treating non
medicaments containing
ibs patients
male ibs
Prior art date
Application number
IL15397201A
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10123447A external-priority patent/DE10123447A1/en
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of IL153972A0 publication Critical patent/IL153972A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/5381,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IL15397201A 2000-07-26 2001-07-18 Medicaments containing cilansetron for treating non-obstipated male ibs patients IL153972A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10036645 2000-07-26
DE10123447A DE10123447A1 (en) 2000-07-26 2001-05-14 Cilansetron-containing medicines for the treatment of non-obstipative male IBS patients
PCT/EP2001/008260 WO2002007713A2 (en) 2000-07-26 2001-07-18 Medicaments containing cilansetron for treating non-obstipated male ibs patients

Publications (1)

Publication Number Publication Date
IL153972A0 true IL153972A0 (en) 2003-07-31

Family

ID=26006529

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15397201A IL153972A0 (en) 2000-07-26 2001-07-18 Medicaments containing cilansetron for treating non-obstipated male ibs patients

Country Status (16)

Country Link
EP (1) EP1307195A2 (en)
JP (1) JP2004504343A (en)
CN (1) CN1444479A (en)
AR (1) AR028970A1 (en)
AU (1) AU2001276409A1 (en)
BR (1) BR0112690A (en)
CA (1) CA2417677A1 (en)
CZ (1) CZ2003158A3 (en)
HU (1) HUP0301479A2 (en)
IL (1) IL153972A0 (en)
MX (1) MXPA02012917A (en)
NO (1) NO20030373D0 (en)
PL (1) PL363517A1 (en)
RU (1) RU2003104798A (en)
SK (1) SK1272003A3 (en)
WO (1) WO2002007713A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0216027D0 (en) 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
CA2516433C (en) * 2004-01-30 2009-06-02 Astellas Pharma Inc. Ramosetron hydrochloride for diarrhea-predominant irritable bowel syndrome
WO2005073220A1 (en) * 2004-01-30 2005-08-11 Yamanouchi Pharmaceutical Co., Ltd. Remedy for irritable bowel syndrome with diarrhea
JP4632204B2 (en) * 2005-09-21 2011-02-16 アステラス製薬株式会社 Antidiarrheal irritable bowel syndrome treatment
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
GB9930077D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
CZ2003158A3 (en) 2003-08-13
AR028970A1 (en) 2003-05-28
EP1307195A2 (en) 2003-05-07
WO2002007713A2 (en) 2002-01-31
RU2003104798A (en) 2004-06-27
MXPA02012917A (en) 2003-05-14
HUP0301479A2 (en) 2003-09-29
NO20030373L (en) 2003-01-24
WO2002007713A3 (en) 2002-11-14
CA2417677A1 (en) 2003-01-27
SK1272003A3 (en) 2003-07-01
CN1444479A (en) 2003-09-24
JP2004504343A (en) 2004-02-12
BR0112690A (en) 2003-06-24
AU2001276409A1 (en) 2002-02-05
NO20030373D0 (en) 2003-01-24
PL363517A1 (en) 2004-11-29

Similar Documents

Publication Publication Date Title
PL363351A1 (en) Oral treatment systems
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU5738801A (en) Implantable hemodialysis access device
HK1044723B (en) Mixing/charging port for medical treatment
GB0008710D0 (en) Therapeutic compounds
GB0016681D0 (en) Therapeutic compounds
HK1047420A1 (en) Medication supplying apparatus
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
HK1044725B (en) Mixing/charging port for medical treatment
HK1044724A1 (en) Mixing/charging port for medical treatment
AU4498201A (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment ofpain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
GB0011807D0 (en) Formulation for inhalation
IL153972A0 (en) Medicaments containing cilansetron for treating non-obstipated male ibs patients
AU3851801A (en) Medical devices suitable for gene therapy regimens
AU2001287884A1 (en) Halogen compounds for use in medicine
GB9906130D0 (en) Compounds for use in therapy
HU0002599D0 (en) Hospital hand trolley for drugs
GB0013105D0 (en) Therapeutic compounds
GB0015079D0 (en) Solution for pharmaceutical use
GB9919721D0 (en) Medical apparatus
AU144122S (en) Rail cam primarily for medical use
GB0008064D0 (en) Patient transfer apparatus
GB0022521D0 (en) Medicinal compounds
GB0007628D0 (en) Medicinal compounds